المؤلفون: Jan Willem B. de Groot, Djura Piersma, John B. A. G. Haanen, Astrid A M van der Veldt, Alfonsus J. M. van den Eertwegh, Christian U. Blank, Gerard Vreugdenhil, Ellen Kapiteijn, Esther Bastiaannet, Monique K van der Kooij, Miranda P Dierselhuis, Marye J Boers-Sonderen, Karijn P M Suijkerbuijk, Albert J. ten Tije, Franchette W P J van den Berkmortel, Marjolein J A L Wetzels, Maureen J.B. Aarts, Rozemarijn S. van Rijn, Michel W.J.M. Wouters, Geke A. P. Hospers

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: van der Kooij, M K, Wetzels, M J A L, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, Dierselhuis, M P, de Groot, J W B, Hospers, G A P, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Haanen, J B A G, van den Eertwegh, A J M, Bastiaannet, E & Kapiteijn, E 2020, ' Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response ', Cancers, vol. 12, no. 8, 2072, pp. 1-15 . https://doi.org/10.3390/cancers12082072Test
Cancers, 12(8):2072, 1-15. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12, 8
Cancers, 12
Cancers
Cancers, 12(8):2072. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12(8):2072, 1-15. MDPI AG
Cancers, Vol 12, Iss 2072, p 2072 (2020)
Cancers, 12(8). MDPI

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, advanced melanoma, young adults, Cancer Research, medicine.medical_specialty, AYA, microbiome, open-label, lcsh:RC254-282, survival, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, METASTATIC MELANOMA, Cumulative incidence, adolescents, Young adult, ipilimumab, Adverse effect, PEMBROLIZUMAB, risk, nivolumab, business.industry, MUTATIONS, prospective nation-wide data, Melanoma, Hazard ratio, clinical audit, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, targeted therapy, humanities, Clinical trial, BRAF mutation, Oncology, 030220 oncology & carcinogenesis, choice chemotherapy, outcome research, business, checkpoint inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7e43ad335ec2975ce6222cf027b69dTest
https://doi.org/10.3390/cancers12082072Test

المؤلفون: Igle J. de Jong, Christian U. Blank, Thomas Powles, Roland Van Velthoven, Maureen J.B. Aarts, Michael A.S. Jewett, Sandrine Marreaud, Sandra Collette, Lori Wood, Sylvie Rottey, Harm H.E. van Melick, Peter F.A. Mulders, John B. A. G. Haanen, Axel Bex, Johannes V. Van Thienen, Jean Baptiste Lattouf, Bertrand Tombal, John Wagstaff, Laurence Collette, Roderick de Bruijn

المساهمون: UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: European Urology, Vol. 76, no. 4, p. 437-440 (2019)
European Urology, 76, 437-440
European Urology, 76(4), 437-440. ELSEVIER SCIENCE BV
European Urology, 76(4), 437-440. Elsevier
European Urology, 76, 4, pp. 437-440

مصطلحات موضوعية: medicine.medical_specialty, Urology, medicine.medical_treatment, 030232 urology & nephrology, PLANNED NEPHRECTOMY, urologic and male genital diseases, THERAPY, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, RENAL-CELL CARCINOMA, Renal cell carcinoma, law, Cytoreductive nephrectomy, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Medicine, Adverse effect, Surgical safety, business.industry, Sunitinib, Mortality rate, Retrospective cohort study, Common Terminology Criteria for Adverse Events, medicine.disease, EFFICACY, Nephrectomy, female genital diseases and pregnancy complications, Surgery, 030220 oncology & carcinogenesis, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0e7e8b92600ad6a6b0194b11b05123Test
https://doi.org/10.1016/j.eururo.2019.06.006Test

المؤلفون: Sanne Patiwael, Christian U. Blank, Ton N. Schumacher, Antoni Ribas, John B. A. G. Haanen, Anastasia Gangaev, Daisy Philips, Dirk Schadendorf, Joost H. van den Berg, Maartje W. Rohaan, Bastian Schilling, Elisa A. Rozeman, Pia Kvistborg, Olga I. Isaeva

المصدر: Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences of the United States of America, vol 118, iss 43

مصطلحات موضوعية: Male, Receptors, Antigen, T-Cell, alpha-beta, Programmed Cell Death 1 Receptor, Medizin, Epitopes, T-Lymphocyte, CD8-Positive T-Lymphocytes, Lymphocyte Activation, Epitope, Cohort Studies, Epitopes, melanoma-reactive CD8 T cells, Receptors, PD-1, 80 and over, Cytotoxic T cell, CTLA-4 Antigen, Hepatitis A Virus Cellular Receptor 2, Immune Checkpoint Inhibitors, Melanoma, Cancer, alpha-beta, Aged, 80 and over, Multidisciplinary, Middle Aged, Biological Sciences, medicine.anatomical_structure, 5.1 Pharmaceuticals, Antigen, Female, Development of treatments and therapeutic interventions, medicine.symptom, Melanoma-Specific Antigens, Adult, Receptors, CXCR5, T cell, In Vitro Techniques, Clinical Research, medicine, Humans, Aged, business.industry, Compartment (ship), T-Cell, medicine.disease, CXCR5, Blockade, Kinetics, T-Lymphocyte, Mechanism of action, CTLA-4, Cancer research, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994323e563648a11d8ffa0127b701604Test
https://doi.org/10.1073/pnas.2102849118Test

المؤلفون: Michel W.J.M. Wouters, Marion Stevense, Ellen Kapiteijn, Christian U. Blank, Karijn P M Suijkerbuijk, Astrid Aplonia Maria Van Der Veldt, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil, Maureen J.B. Aarts, Liesbeth C. de Wreede, Jesper van Breeschoten, Erik W. van Zwet, John B. A. G. Haanen, Jan Willem B. de Groot, Franchette W P J van den Berkmortel, Marye Boers-Sonderen, Doranne L. Hilarius

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Medical Oncology, Radiology & Nuclear Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: Cancers, 13(20):5077. MDPI AG
Cancers, 13, 20
van Breeschoten, J, van den Eertwegh, A J M, de Wreede, L C, Hilarius, D L, van Zwet, E W, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-sonderen, M J, Suijkerbuijk, K P M & Wouters, M W J M 2021, ' Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients : Nationwide quality assurance in the netherlands ', Cancers, vol. 13, no. 20, 5077 . https://doi.org/10.3390/cancers13205077Test
Cancers, 13(20):5077. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 5077, p 5077 (2021)
Cancers, 13(20). MDPI
Cancers
Volume 13
Issue 20
Cancers, 13

مصطلحات موضوعية: Oncology, advanced melanoma, Cancer Research, medicine.medical_specialty, Metastatic melanoma, IMPACT, MULTICENTER, survival, VEMURAFENIB, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], POOLED ANALYSIS, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, medicine, METASTATIC MELANOMA, Quality of care, RC254-282, Advanced melanoma, business.industry, center variation, Melanoma, Significant difference, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, Random effects model, DABRAFENIB, Stage iv melanoma, business, Quality assurance

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d369fca07c88bdc71e6f5d5567757c91Test
https://hdl.handle.net/11370/144a687b-1f76-44fd-acca-1d9813cd82c3Test

المؤلفون: Geke A. P. Hospers, Marye J Boers-Sonderen, Christian U. Blank, John B. A. G. Haanen, Karlijn P. M. Suijkerbuijk, Albert J. ten Tije, Esther Bastiaannet, Ellen Kapiteijn, Astrid A M van der Veldt, Frederiek van den Bos, Nienke A. de Glas, Jan-Willem B de Groot, Simon P. Mooijaart, Johanneke E.A. Portielje, Maureen J.B. Aarts, Hilde Jalving, Alfonsus J. M. van den Eertwegh, Rozemarijn S. van Rijn, Gerard Vreugdenhil, Michel W.J.M. Wouters, Franchette W P J van den Berkmortel, Djura Piersma

المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: Cancers, 13, 11
Cancers
Volume 13
Issue 11
Cancers, 13(11). Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(11). MDPI
Cancers, 13
Cancers, 13(11):2826. MDPI AG
Cancers, Vol 13, Iss 2826, p 2826 (2021)
Cancers, 13(11):2826. Multidisciplinary Digital Publishing Institute (MDPI)

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, IMPACT, Article, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, GERIATRIC ASSESSMENT, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, AGE, Quality of life, Internal medicine, melanoma, Medicine, COHORT, 030212 general & internal medicine, geriatric oncology, RC254-282, older adults, OUTCOMES, response, Performance status, CHEMOTHERAPY TOXICITY, Proportional hazards model, business.industry, IPILIMUMAB, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, toxicity, medicine.disease, Comorbidity, Discontinuation, Oncology, Geriatric oncology, COMBINED NIVOLUMAB, 030220 oncology & carcinogenesis, SAFETY, Cohort, Toxicity, immunotherapy, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d55e3790cfe21ed7ffce9d4951754c49Test
https://doi.org/10.3390/cancers13112826Test

المؤلفون: Michele W.L. Teng, Michael A. Postow, Reinhard Dummer, Claus Garbe, Paolo A. Ascierto, Christian U. Blank, Iman Osman, Michelle Krogsgaard, Patrick Hwu, Magdalena Thurin, Bernard A. Fox, Soldano Ferrone, Thomas F. Gajewski, Marc S. Ernstoff, Bart Neyns, Sergio A. Quezada, Igor Puzanov, Pawel Kalinski, Jason J. Luke, Roger S. Lo, Corrado Caracò, A. Testori, Giorgio Trinchieri

المساهمون: Clinical sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, University of Zurich, Ascierto, Paolo A

المصدر: Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-18 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, BRAF inhibitor, medicine.medical_specialty, medicine.medical_treatment, 610 Medicine & health, Genetics and Molecular Biology, Translational research, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Melanoma, Adjuvant, Combination strategies, Tumor microenvironment, MEK inhibitor, business.industry, 10177 Dermatology Clinic, General Medicine, medicine.disease, Precision medicine, Immune checkpoint, Anti-PD-1, 030104 developmental biology, 030220 oncology & carcinogenesis, General Biochemistry, oncology, Biomarker (medicine), Medicine, Immunotherapy, Neoadjuvant, business, Biomarkers

وصف الملف: 910_Ascierto_PA._et_al._Perspectives_in_Melanoma_meeting_report_from_the_Melanoma_Bridge_(December_3rd-5th,_2020,_Italy)_J_Transl_Med_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ae34e331a3034551bf810df26f0f3Test
http://europepmc.org/articles/PMC8243582Test

المؤلفون: B.A. van de Wiel, Charlotte L. Zuur, Serigne Lo, Michel W.J.M. Wouters, Carolien Bierman, María Jesús González González, Elena Shklovskaya, Christian U. Blank, Willem M.C. Klop, Elisa A. Rozeman, Robert V. Rawson, J.B.A.G. Haanen, Omgo E. Nieweg, James S. Wilmott, Andrew J. Spillane, Robyn P. M. Saw, J.V. van Thienen, C. Adhikari, Sydney Ch'ng, A.C.J. van Akkooi, Michael T. Tetzlaff, Hanna Eriksson, Helen Rizos, Alexander Guminski, Richard A. Scolyer, Kerwin F. Shannon, W.J. van Houdt, Jonathan R. Stretch, Georgina V. Long, A.M. Menzies

المصدر: Annals of Oncology, 32(6), 766-777. ELSEVIER

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, 03 medical and health sciences, 0302 clinical medicine, Fibrosis, Internal medicine, medicine, Humans, Melanoma, Pathological, Lymph node, business.industry, neoadjuvant, Reproducibility of Results, Hematology, Immunotherapy, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, Nivolumab, business, pathological response, medicine.drug, metastatic melanoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb61a837c13200f2514a9ed7c1f22afTest
https://hdl.handle.net/1887/3276136Test

المؤلفون: J.B.A.G. Haanen, Christian U. Blank, Karijn P M Suijkerbuijk, G. Vreugdenhil, A.A.M. Van der Veldt, Mieke J. Aarts, Ellen Kapiteijn, F.W.P.J. van den Berkmortel, Marye J Boers-Sonderen, A.J.M. van den Eertwegh, R van Rijn, Djura Piersma, Gap Hospers, J.W.B. de Groot, H.M. Westgeest

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: JEADV : Journal of the European Academy of Dermatology and Venereology, 36, 2, pp. e118-e119
Suijkerbuijk, K P M, Haanen, J B A G, Boers-Sonderen, M J, Hospers, G A P, Blank, C U, van den Berkmortel, F W P J, de Groot, J W B, Piersma, D, Aarts, M J B, van Rijn, R S, Vreugdenhil, G, Westgeest, H M, Kapiteijn, E, van der Veldt, A A M & van den Eertwegh, A J M 2022, ' Survival of stage IV melanoma in Belgium and the Netherlands ', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 2, pp. e118-e119 . https://doi.org/10.1111/jdv.17668Test
Journal of the European Academy of Dermatology and Venereology, 36(2), E118-E119. Wiley
JEADV : Journal of the European Academy of Dermatology and Venereology, 36, e118-e119
Journal of the European Academy of Dermatology and Venereology, 36(2), e118-e119. Wiley-Blackwell
Journal of the European Academy of Dermatology and Venereology, 36(2), e118-e119. Wiley

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Dermatology, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Infectious Diseases, SDG 3 - Good Health and Well-being, Belgium, Internal medicine, medicine, Stage iv melanoma, Humans, Registries, business, Melanoma, Advanced melanoma, Netherlands

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d230b3e3b6a80b158e9d9fb316e3893bTest
https://pubmed.ncbi.nlm.nih.gov/34534376Test

المؤلفون: Melissa Melanie de Meza, Jan Willem B. de Groot, Christian U. Blank, John B. A. G. Haanen, Geke A. P. Hospers, Michel W.J.M. Wouters, Karijn P M Suijkerbuijk, Marye Boers-Sonderen, Maureen J.B. Aarts, Willeke A. M. Blokx, Ellen Kapiteijn, Hans M. Westgeest, Astrid Aplonia Maria Van Der Veldt, Rozemarijn S. van Rijn, Alexander C.J. van Akkooi, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Gerard Vreugdenhil, Rawa K Ismail, Djura Piersma

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Journal of Clinical Oncology, 39(15). AMER SOC CLINICAL ONCOLOGY

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Melanoma, medicine.medical_treatment, Population based, medicine.disease, Clinical Practice, Internal medicine, Medicine, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df8a000f005c1d70904c88bae3789359Test
https://research.rug.nl/en/publications/9b12c0df-5edb-46d5-84e8-c3768f8bbcf0Test

المؤلفون: Nienke A. de Glas, Christian U. Blank, Alfonsus J. M. van den Eertwegh, Michel W.J.M. Wouters, Geke A. P. Hospers, Ellen Kapiteijn, Karijn P M Suijkerbuijk, Maureen J.B. Aarts, Marye Boers-Sonderen, Frederiek van den Bos, Astrid Aplonia Maria Van Der Veldt, Franchette W P J van den Berkmortel, Simon P. Mooijaart, Rozemarijn S. van Rijn, Esther Bastiaannet, A.J. ten Tije, J.E.A. Portielje, John B. A. G. Haanen, Djura Piersma, Jan Willem B. de Groot

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Journal of Clinical Oncology, 39(15). AMER SOC CLINICAL ONCOLOGY

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Metastatic melanoma, business.industry, Internal medicine, Immune checkpoint inhibitors, Toxicity, medicine, Improved survival, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c8f4633388d1d9c220df28c2e59c52Test
https://doi.org/10.1200/jco.2021.39.15_suppl.9544Test